MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$422M
AUM Growth
+$62.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$21.8M
2
+$18.8M
3
+$16.4M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$4.79M
5
INBX
Inhibrx, Inc. Common Stock
INBX
+$4.61M

Top Sells

1
+$5.04M
2
+$4.02M
3
+$2.53M
4
NEO icon
NeoGenomics
NEO
+$1.1M
5
FOLD icon
Amicus Therapeutics
FOLD
+$1.07M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.99M 0.71%
+304,027
27
$2.91M 0.69%
44,747
-253
28
$2.88M 0.68%
146,041
29
$2.76M 0.65%
270,388
30
$2.14M 0.51%
193,326
31
$2.07M 0.49%
412,363
32
$2.04M 0.48%
97,322
-191,209
33
$2.02M 0.48%
2,377,031
34
$1.77M 0.42%
661,144
-3,836
35
$1.61M 0.38%
334,384
36
$738K 0.17%
405,700
-255,192
37
$416K 0.1%
53,993
38
$405K 0.1%
239,888
39
– –
-20,000
40
– –
-3,425,202
41
– –
-135,573
1
2